Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PulteGroup | PHM | Oct 30, 2024 | 130.26 | +0.52 |
Puma Biotechnology | PBYI | Oct 30, 2024 | 2.84 | +1.79 |
Pure Cycle | PCYO | Oct 30, 2024 | 10.59 | -3.38 |
Pure Storage A | PSTG | Oct 30, 2024 | 53.41 | -3.01 |
PureCycle Technologies | PCT | Oct 30, 2024 | 13.48 | -3.71 |
PureCycle Technologies Unit | PCTTU | Oct 30, 2024 | 17.12 | 0.00 |
Purefunds ISE Junior Silver [Sm | SILJ | Oct 30, 2024 | 14.31 | -2.39 |
PureTech Health ADR | PRTC | Oct 30, 2024 | 20.84 | +0.48 |
Purple Biotech ADR | PPBT | Oct 30, 2024 | 3.30 | -5.17 |
Purple Innovation | PRPL | Oct 30, 2024 | 0.89 | -1.65 |
Putnam Managed Municipal Income Trust | PMM | Oct 30, 2024 | 6.26 | +0.97 |
Putnam Master Intermediate Income Trust | PIM | Oct 30, 2024 | 3.28 | +0.31 |
Putnam Municipal Opportunities Trust | PMO | Oct 30, 2024 | 10.51 | +0.77 |
Putnam Premier Income Trust | PPT | Oct 30, 2024 | 3.60 | +0.84 |
PVH | PVH | Oct 30, 2024 | 98.81 | -0.05 |
Pyrophyte Acquisition | PHYT | Oct 30, 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Oct 30, 2024 | 3.77 | -1.31 |
Pyxis Tankers | PXS | Oct 30, 2024 | 4.37 | +1.04 |
Pyxis Tankers Pref | PXSAP | Oct 30, 2024 | 24.97 | 0.00 |
Q2 | QTWO | Oct 30, 2024 | 85.64 | +0.98 |
Q32 Bio | QTTB | Oct 30, 2024 | 46.32 | -1.91 |
QCR | QCRH | Oct 30, 2024 | 81.29 | +0.25 |
QIAGEN | QGEN | Oct 30, 2024 | 42.24 | +0.98 |
Qifu Technology ADR | QFIN | Oct 30, 2024 | 33.64 | -1.41 |
Qilian International | QLI | Oct 30, 2024 | 5.41 | 0.00 |
Qilian International | BGM | Oct 30, 2024 | 7.41 | 0.00 |
QMMM | QMMM | Oct 30, 2024 | 9.80 | +5.38 |
Qomolangma Acquisition | QOMO | Oct 30, 2024 | 11.40 | 0.00 |
Qorvo | QRVO | Oct 30, 2024 | 73.04 | -27.31 |
QT Imaging | QTI | Oct 30, 2024 | 0.74 | -1.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.